Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (11)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (11)
Translational Vision Science & Technology (1)

Article Type

ARVO Annual Meeting Abstract (11)
Articles (1)

Topics

Eye Anatomy and Disorders (1)
Genetics (1)
Nanotechnology and Regenerative Medicine (1)
Pharmacology (1)
Retina (1)
Translational Research (1)

Tags

aflibercept (1)
anti-vascular endothelial growth factor therapy (1)
eye (1)
gene therapy (1)
primates (1)
retina (1)
safety (1)
vascular endothelial growth factor a (1)

Specify Date Range

From: To: Apply

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Phase 1 Study of Intravitreal Gene Therapy with ADVM-022 for neovascular AMD (OPTIC Trial)

Brandon Busbee; David S Boyer; Arshad M. Khanani; Charles Clifton Wykoff; Dante Joseph Pieramici; Carl Regillo; Carl J Danzig; Brian C Joondeph; James Major; Carol Hoang; Adam Turpcu; Carol Chung; Szilard Kiss; Mehdi Gasmi; Aaron Osborne

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):352.

ARVO Annual Meeting Abstract June 2021

Preclinical Evaluation of ADVM-062, a Novel Intravitreal Gene Therapy for the Treatment of Blue Cone Monochromacy

Ruslan Grishanin; Diana Cepeda; Julio Nieves; Christine Dowd; Pallavi Sharma; Alexa Levinson; Kelly Hanna; Kristina Oresic Bender; Baljit Singh; Dawn Duffield; Rathna Veeramachaneni; Mark Renz; Judith Greengard; James Ver Hoeve; Mehdi Gasmi; Claire Gelfman

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1191.

Articles January 2021

Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates

PDF

Szilárd Kiss; Kristina Oresic Bender; Ruslan N. Grishanin; Kelly M. Hanna; Julio D. Nieves; Pallavi Sharma; Aivan T. Nguyen; Romeo J. Rosario; Judith S. Greengard; Claire M. Gelfman; Mehdi Gasmi
TAGS: aflibercept, anti-vascular endothelial growth factor therapy, gene therapy, safety, eye, primates, retina, vascular endothelial growth factor a
Trans. Vis. Sci. Tech.. 2021; 10(1):34. https://doi.org/10.1167/tvst.10.1.34

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Intravitreal delivery of AAV2.7m8.ranibizumab suppresses exudative lesions in the NHP laser induced model of nAMD

Kristina Bender; Ruslan Grishanin; Aivan Nguyen; Pallavi Sharma; Judith Greengard; Szilard Kiss; Claire Gelfman; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4492.

ARVO Annual Meeting Abstract June 2020

Mouse Studies Support Intravitreal Gene Therapy for Blue Cone Monochromacy

Ruslan Grishanin; Diana Cepeda; James Ver Hoeve; Christine Dowd; Kristina Bender; Kelly Hanna; Julio Nieves; Edward Yeh; Pallavi Sharma; Claire Gelfman; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4499.

ARVO Annual Meeting Abstract July 2019

Immunological response and durability of expression following sequential intravitreal administration of AAV2.7m8 gene therapy to the contralateral eye in non-human primates

Diana Cepeda; Edward Yeh; Julio Nieves; Carolina Ceballos Diaz; Awilda Rosario; Judith Greengard; Claire Gelfman; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2910.

ARVO Annual Meeting Abstract July 2018

Long-term functional delivery of the human L-opsin cDNA via intravitreal administration of an AAV vector in Mongolian gerbils.

Diana Cepeda; Jim Ver Hoeve; Ming Ni; Annahita Keravala; Angelica Phillips; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5696.

ARVO Annual Meeting Abstract June 2017

Assessment of next-generation AAV variants in gerbil and non-human primate retina following intravitreal injection

Annahita Keravala; Yu-Shan Tseng; Tawny Neal; Ming Ni; Christopher Chavez; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4097.

ARVO Annual Meeting Abstract September 2016

In vivo assessment of the impact of neutralizing antibodies on intravitreal AAV2.7m8 administration

Annahita Keravala; Kathryn W Woodburn; Sharmila Vijay; Carmelo Romano; Stanley J Wiegand; Andrew Murphy; Thomas Walter Chalberg; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):782.

ARVO Annual Meeting Abstract September 2016

Evaluation of AAV Variants for Transgene Expression and Distribution in Rabbits and Non-Human Primate Eyes Following Intravitreal Delivery

Bibiana Veronica Iglesias; Kathryn W Woodburn; Jingtai Cao; Stanley J Wiegand; Annahita Keravala; Carmelo Romano; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):786.

ARVO Annual Meeting Abstract September 2016

Intraocular gene expression and functional safety evaluation following intravitreal delivery of cone specific GFP-expressing AAV vectors in nonhuman primates

Kathryn W Woodburn; Steven J Samuelsson; Sharmila Vijay; Thomas Walter Chalberg; Vernard Woodley; Jordan Attwood; Matthew S Lawrence; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Anatomical and functional effects of subretinal rAAV.sVEGFR-1 gene therapy on retinal-choroidal structures in nonhuman primates

Sharmila Vijay; Kathryn W Woodburn; Pallavi Sharma; Thomas Walter Chalberg; Vernard Woodley; Jordan Attwood; Matthew S Lawrence; Mehdi Gasmi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3369.

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2025 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept